SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-22-019024
Filing Date
2022-08-05
Accepted
2022-08-05 08:02:16
Documents
16
Period of Report
2022-07-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A vxrt20220802_8ka.htm   iXBRL 8-K/A 44639
2 EXHIBIT 10.1 ex_405588.htm EX-10.1 152692
3 EXHIBIT 10.2 ex_405589.htm EX-10.2 95264
4 EXHIBIT 99.1 ex_407070.htm EX-99.1 12868
  Complete submission text file 0001437749-22-019024.txt   505350

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20220706.xsd EX-101.SCH 3600
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20220706_def.xml EX-101.DEF 11903
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20220706_lab.xml EX-101.LAB 15928
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20220706_pre.xml EX-101.PRE 12114
10 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20220802_8ka_htm.xml XML 2676
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35285 | Film No.: 221138654
SIC: 2836 Biological Products, (No Diagnostic Substances)